{"title":"依托咪酯通过Nrf2/HO-1途径保护视网膜神经节细胞免受过氧化氢诱导的损伤","authors":"Xuan Zhao, De-Gang Fan, Xin-Chao Zhang, Si-Wei You, Fang Kuang, Ming-Mei Wu","doi":"10.18240/ijo.2024.09.05","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To determine whether etomidate (ET) has a protective effect on retinal ganglion cells (RGCs) injured with hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and to explore the potential mechanism underlying the antioxidative stress effect of ET.</p><p><strong>Methods: </strong>Cultured RGCs were identified by double immunofluorescent labeling of microtubule-associated protein 2 and Thy1.1. An injury model of H<sub>2</sub>O<sub>2</sub>-induced RGCs oxidative stress was established <i>in vitro</i>. Cells were pretreated with different concentrations of ET (1, 5, and 10 µmol/L) for 4h, followed by further exposure to H<sub>2</sub>O<sub>2</sub> at 1000 µmol/L. Cell counting kit 8 and Annexin V/propidium iodide assays were applied to detect the viabilities and apoptosis rates of the RGCs at 12, 24, and 48h after H<sub>2</sub>O<sub>2</sub> stimulation. The levels of nitric oxide, malondialdehyde, and glutathione in culture media were measured at these time points. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot were performed to observe the effects of ET on the messenger RNA and protein expression of inducible nitric oxide synthase (iNOS), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase 1 (HO-1), glutathione peroxidase 1 and the level of conjugated acrolein in RGCs at 12, 24, and 48h after H<sub>2</sub>O<sub>2</sub> stimulation and in the retina at 12h after optic nerve transection (ONT).</p><p><strong>Results: </strong>The applications of 5 and 10 µmol/L of ET significantly increased the viability of RGCs. Results from qRT-PCR indicated a decrease in the expression of iNOS and an increase in the expressions of Nrf2 and HO-1 in ET-pretreated RGCs at 12, 24 and 48h after H<sub>2</sub>O<sub>2</sub> stimulation, as well as in ET-treated retinas at 12h after ONT. Western blot analysis revealed a decrease in the expression of iNOS and levels of conjugated acrolein, along with an increase in the expressions of Nrf2 and HO-1 in ET-pretreated RGCs <i>in vitro</i> and ET-treated retinas <i>in vivo</i>.</p><p><strong>Conclusion: </strong>ET is a neuroprotective agent in primary cultured RGCs injured by H<sub>2</sub>O<sub>2</sub>. The effect of ET is dose-dependent with the greatest effect being at 10 µmol/L. ET plays an antioxidant role by inhibiting iNOS, up-regulating Nrf2/HO-1, decreasing the production of acrolein, and increasing the scavenge of acrolein.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"17 9","pages":"1606-1613"},"PeriodicalIF":1.9000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367447/pdf/","citationCount":"0","resultStr":"{\"title\":\"Etomidate protects retinal ganglion cells from hydrogen peroxide-induced injury <i>via</i> Nrf2/HO-1 pathway.\",\"authors\":\"Xuan Zhao, De-Gang Fan, Xin-Chao Zhang, Si-Wei You, Fang Kuang, Ming-Mei Wu\",\"doi\":\"10.18240/ijo.2024.09.05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>To determine whether etomidate (ET) has a protective effect on retinal ganglion cells (RGCs) injured with hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and to explore the potential mechanism underlying the antioxidative stress effect of ET.</p><p><strong>Methods: </strong>Cultured RGCs were identified by double immunofluorescent labeling of microtubule-associated protein 2 and Thy1.1. An injury model of H<sub>2</sub>O<sub>2</sub>-induced RGCs oxidative stress was established <i>in vitro</i>. Cells were pretreated with different concentrations of ET (1, 5, and 10 µmol/L) for 4h, followed by further exposure to H<sub>2</sub>O<sub>2</sub> at 1000 µmol/L. Cell counting kit 8 and Annexin V/propidium iodide assays were applied to detect the viabilities and apoptosis rates of the RGCs at 12, 24, and 48h after H<sub>2</sub>O<sub>2</sub> stimulation. The levels of nitric oxide, malondialdehyde, and glutathione in culture media were measured at these time points. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot were performed to observe the effects of ET on the messenger RNA and protein expression of inducible nitric oxide synthase (iNOS), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase 1 (HO-1), glutathione peroxidase 1 and the level of conjugated acrolein in RGCs at 12, 24, and 48h after H<sub>2</sub>O<sub>2</sub> stimulation and in the retina at 12h after optic nerve transection (ONT).</p><p><strong>Results: </strong>The applications of 5 and 10 µmol/L of ET significantly increased the viability of RGCs. Results from qRT-PCR indicated a decrease in the expression of iNOS and an increase in the expressions of Nrf2 and HO-1 in ET-pretreated RGCs at 12, 24 and 48h after H<sub>2</sub>O<sub>2</sub> stimulation, as well as in ET-treated retinas at 12h after ONT. Western blot analysis revealed a decrease in the expression of iNOS and levels of conjugated acrolein, along with an increase in the expressions of Nrf2 and HO-1 in ET-pretreated RGCs <i>in vitro</i> and ET-treated retinas <i>in vivo</i>.</p><p><strong>Conclusion: </strong>ET is a neuroprotective agent in primary cultured RGCs injured by H<sub>2</sub>O<sub>2</sub>. The effect of ET is dose-dependent with the greatest effect being at 10 µmol/L. ET plays an antioxidant role by inhibiting iNOS, up-regulating Nrf2/HO-1, decreasing the production of acrolein, and increasing the scavenge of acrolein.</p>\",\"PeriodicalId\":14312,\"journal\":{\"name\":\"International journal of ophthalmology\",\"volume\":\"17 9\",\"pages\":\"1606-1613\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367447/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.18240/ijo.2024.09.05\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2024.09.05","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:确定依托咪酯(ET)是否对受到过氧化氢(H2O2)损伤的视网膜神经节细胞(RGC)具有保护作用,并探讨ET抗氧化应激效应的潜在机制:方法:培养的RGC通过微管相关蛋白2和Thy1.1的双重免疫荧光标记进行鉴定。在体外建立了 H2O2 诱导的 RGCs 氧化应激损伤模型。用不同浓度的ET(1、5和10 µmol/L)预处理细胞4小时,然后将细胞暴露于1000 µmol/L的H2O2。应用细胞计数试剂盒8和Annexin V/碘化丙啶检测H2O2刺激后12、24和48小时RGCs的存活率和凋亡率。在这些时间点测量了培养基中一氧化氮、丙二醛和谷胱甘肽的水平。通过定量反转录聚合酶链反应(qRT-PCR)和 Western 印迹法观察 ET 对诱导型一氧化氮合酶(iNOS)的信使 RNA 和蛋白表达的影响、核因子红细胞2相关因子2(Nrf2)、血红素加氧酶1(HO-1)、谷胱甘肽过氧化物酶1以及共轭丙烯醛水平的影响。结果:5 µmol/L 和 10 µmol/L 的 ET 能显著提高 RGC 的存活率。qRT-PCR 结果表明,在 H2O2 刺激后 12、24 和 48 小时,ET 预处理的 RGC 中 iNOS 的表达量减少,Nrf2 和 HO-1 的表达量增加;在 ONT 后 12 小时,ET 处理的视网膜中 iNOS 的表达量减少,Nrf2 和 HO-1 的表达量增加。Western blot 分析显示,在体外经 ET 处理的 RGCs 和体内经 ET 处理的视网膜中,iNOS 的表达和共轭丙烯醛的水平均有所下降,而 Nrf2 和 HO-1 的表达则有所增加:结论:ET对受H2O2损伤的原代培养RGC具有神经保护作用。ET的作用与剂量有关,10 µmol/L时作用最大。ET 通过抑制 iNOS、上调 Nrf2/HO-1、减少丙烯醛的产生和增加对丙烯醛的清除发挥抗氧化作用。
Etomidate protects retinal ganglion cells from hydrogen peroxide-induced injury via Nrf2/HO-1 pathway.
Aim: To determine whether etomidate (ET) has a protective effect on retinal ganglion cells (RGCs) injured with hydrogen peroxide (H2O2) and to explore the potential mechanism underlying the antioxidative stress effect of ET.
Methods: Cultured RGCs were identified by double immunofluorescent labeling of microtubule-associated protein 2 and Thy1.1. An injury model of H2O2-induced RGCs oxidative stress was established in vitro. Cells were pretreated with different concentrations of ET (1, 5, and 10 µmol/L) for 4h, followed by further exposure to H2O2 at 1000 µmol/L. Cell counting kit 8 and Annexin V/propidium iodide assays were applied to detect the viabilities and apoptosis rates of the RGCs at 12, 24, and 48h after H2O2 stimulation. The levels of nitric oxide, malondialdehyde, and glutathione in culture media were measured at these time points. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot were performed to observe the effects of ET on the messenger RNA and protein expression of inducible nitric oxide synthase (iNOS), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase 1 (HO-1), glutathione peroxidase 1 and the level of conjugated acrolein in RGCs at 12, 24, and 48h after H2O2 stimulation and in the retina at 12h after optic nerve transection (ONT).
Results: The applications of 5 and 10 µmol/L of ET significantly increased the viability of RGCs. Results from qRT-PCR indicated a decrease in the expression of iNOS and an increase in the expressions of Nrf2 and HO-1 in ET-pretreated RGCs at 12, 24 and 48h after H2O2 stimulation, as well as in ET-treated retinas at 12h after ONT. Western blot analysis revealed a decrease in the expression of iNOS and levels of conjugated acrolein, along with an increase in the expressions of Nrf2 and HO-1 in ET-pretreated RGCs in vitro and ET-treated retinas in vivo.
Conclusion: ET is a neuroprotective agent in primary cultured RGCs injured by H2O2. The effect of ET is dose-dependent with the greatest effect being at 10 µmol/L. ET plays an antioxidant role by inhibiting iNOS, up-regulating Nrf2/HO-1, decreasing the production of acrolein, and increasing the scavenge of acrolein.
期刊介绍:
· International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication
and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online).
This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from
WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed,
PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166.
IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific
Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO);
Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President,
Chinese Academy of Engineering.
International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of
blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of
AAO/PAAO) et al.
Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of
Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and
Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society).
Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press).
Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and
Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics).
Associate Editors-in-Chief include:
Prof. Ning-Li Wang (President Elect of APAO);
Prof. Ke Yao (President of Chinese Ophthalmological Society) ;
Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ;
Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA);
Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society);
Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA);
Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA).
IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles,
both basic and clinical papers.
Instruction is Welcome Contribution is Welcome Citation is Welcome
Cooperation organization
International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.